Efficient Access to Domain-Integrated Estradiol-Flavone Hybrids Via the Corresponding Chalcones and Their in Vitro Anticancer Potential † ‡

44 Pages Posted: 27 May 2022

See all articles by Barnabás Molnár

Barnabás Molnár

University of Szeged

Mohana K. Gopisetty

University of Szeged

Ferenc István Nagy

University of Szeged

Dóra Izabella Adamecz

University of Szeged

Zsolt Kása

University of Szeged - Institute of Chemistry

Mónika Kiricsi

University of Szeged

Éva Frank

University of Szeged - Doctoral School of Chemistry

Abstract

Structural modification of the phenolic A-ring of estrogens at C-2 and/or C-3 significantly reduces or eliminates the hormonal effects of the compounds, thus the incorporation of other pharmacophores into these positions can provide biologically active derivatives suitable for new indications, without possessing unwanted side effects. As part of this work, A-ring integration of estradiol with chalcones and flavones was carried out in the hope of obtaining novel molecular hybrids with anticancer action. The syntheses were performed from 2-acetylestradiol-17β-acetate which was first reacted with various (hetero)aromatic aldehydes in a pyrrolidine-catalyzed reaction in DMSO. The chalcones thus obtained were then subjected to oxidative cyclization with I2 in DMSO to afford estradiol-flavone hybrids in good yields. All newly synthesized derivatives were tested in vitro for cytotoxicity on human malignant cell lines of diverse origins as well as on a non-cancerous cell line, and the results demonstrated that estradiol-flavone hybrids containing a structure-integrated flavone moiety were the most active and cancer cell-selective agents. The minimal inhibitory concentration values (IC50) were calculated for selected compounds and their apoptosis inducing capacity was verified by RT-qPCR (real time quantitative polymerase chain reaction). The results suggest an important structure−activity relationship regarding estradiol-flavone hybrids that could form a promising synthetic platform and rationale for future drug developments.

Note:
Funding Information: This research was supported by the New National Excellence Program of the Ministry for Innovation and Technology from the National Research, Development, and Innovation Fund (ÚNKP-21-5-SZTE-592 to M.K, ÚNKP-21-2-SZTE-356 to F.I.N) and the János Bolyai Research Scholarship of the Hungarian Academy of Sciences (BO/00878/19/8 to M.K.). This research work was conducted with the support of the National Scientists Academy under the sponsorship of the Hungarian Ministry of Innovation and Technology (FEIF/433-4/2020-ITM to F.I.N.). Financial support by EC H2020 project “METROFOOD-PP” (grant agreement No 871083) is gratefully acknowledged.

Declaration of Interests: There are no conflicts to declare.

Keywords: steroid, molecular hybridization, chalcone, flavone, antiproliferative activity

Suggested Citation

Molnár, Barnabás and Gopisetty, Mohana K. and Nagy, Ferenc István and Adamecz, Dóra Izabella and Kása, Zsolt and Kiricsi, Mónika and Frank, Éva, Efficient Access to Domain-Integrated Estradiol-Flavone Hybrids Via the Corresponding Chalcones and Their in Vitro Anticancer Potential † ‡. Available at SSRN: https://ssrn.com/abstract=4120924 or http://dx.doi.org/10.2139/ssrn.4120924

Barnabás Molnár

University of Szeged ( email )

Mohana K. Gopisetty

University of Szeged ( email )

Ferenc István Nagy

University of Szeged ( email )

Dóra Izabella Adamecz

University of Szeged ( email )

Zsolt Kása

University of Szeged - Institute of Chemistry ( email )

Mónika Kiricsi

University of Szeged ( email )

Éva Frank (Contact Author)

University of Szeged - Doctoral School of Chemistry ( email )

Hungary

Do you have a job opening that you would like to promote on SSRN?

Paper statistics

Downloads
60
Abstract Views
221
Rank
720,001
PlumX Metrics